Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.6B | 7.7B | 7.6B | 7.7B |
Cost of revenue | 6.3B | 6.5B | 6.3B | 6.4B |
Gross profit | 1.3B | 1.3B | 1.2B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 913.6M | 886M | 885.2M | 887.5M |
Other operating expenses | — | — | — | — |
Operating income | 315.5M | 333.8M | 317.4M | 338M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 64M | 71.3M | 73.7M | 66.5M |
Other income expense | 85.6M | 52.7M | 60.7M | 54M |
Pretax income | 337.1M | 315.2M | 304.4M | 325.5M |
Tax provision | 92.1M | 77.9M | 77.4M | 82.6M |
Net income | 245M | 237.3M | 227M | 242.9M |
Basic EPS | 3.7 | 3.5 | 3.4 | 3.6 |
Diluted EPS | 3.7 | 3.5 | 3.4 | 3.6 |
Basic average shares | 66.8M | 66.8M | 66.8M | 66.9M |
Diluted average shares | 66.8M | 66.8M | 66.8M | 66.9M |
EBITDA | 388.7M | 427.5M | 418.7M | 430.6M |
Net income from continuing op. | 245M | 237.3M | 227M | 242.9M |
Minority interests | -700K | -900K | -900K | -1.7M |
Preferred stock dividends | — | — | — | — |